Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 11 -20 of 1230 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer				Phase IV				CZOL446EDE28 NCT00334139
	EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer				Phase IV				EGF103659 NCT00338247
	Pharmacogenetics as a Predictor of Toxicity in Pre-Menopausal Women Receiving Doxorubicin and Cyclophosphamide in Early Breast Cancer				Phase IV				0501-37 NCT00352872
	The Efficacy of Prophylactic Antibiotic Administration During Breast Cancer Surgery in Overweight Patients.				Phase IV				MAR-YC-2003-0111 NCT00356148
	Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions				Phase IV				CZOL446EIT14 NCT00375427
	A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES)				Phase IV				AVF3991n NCT00388206
	Antifungal Use in Oncohematological Neutropenic Patients				Phase IV				2005-004973-55 ANTIVORIFUNGOL, NCT00386802
	National Screening in Denmark With MR Versus Mammography and Ultrasound of Women With BRCA1 or BRCA2 Mutations				Phase IV				DBCG07MRBRCA DBCG07MRBRCA, NCT00413491
	Doxorubicin Hydrochloride Liposome or Capecitabine as First-Line Chemotherapy in Treating Women With Metastatic Breast Cancer				Phase IV				SPRI-P04445 EU-20654, NCT00266799, SPRI-PELICAN
	Effect of Eszopiclone on Sleep Disturbance & Pain in Cancer				Phase IV				UCSD 060340 ESRC 054, NCT00365261


					< Previous 1 2 3 4 5 Next >

| | | | | | | |

A Service of the National Cancer Institute